A webinar was held on 6 July 2022 on how diagnostics companies should respond to new NHS systems and policies, and the new integrated care systems (ICS). The event featured expert advice from Shailen Rao (Managing Director of Soar Beyond) and BIVDA COO Helen Dent.BIVDA members can find the recording of the webinar through this YouTube link here: https://youtu.be/ySVYC30pSVc 

BSI, BEIS and the Race to Zero campaign are working together to supply 100,000 free copies to help small and medium-sized businesses reach Net Zero.

Please click here for important updates on these topics.

The Bill is seeking to tear up trade rules set out in the Protocol and replace these with a two-stream system of goods flow via or towards Northern Ireland.

The North East Innovation Lab has played a key role in a successful study to develop a new biosensor which could be used in Covid-19 diagnostic tests.

BIVDA welcomes MHRA’s formal response to the consultation on future regulation of medical devices in the UK The response to the consultation on the new UK Regulatory Framework for medical devices was published on 26 June 2022. This is a huge step for regulation in the UK and gives an insight into what can be expected when the regulations are published. Totalling 16 chapters and spanning 155 pages, the response is very comprehensive and detailed. This depth has been anticipated by the ...

New data has been made available on patient wait times for tests, diagnostic activities and referrals.

Researchers from France have pioneered a new blood test which can distinguish between unipolar and bipolar depression – a world first.

A new letter has been sent to over 200,000 businesses about the Customs Declaration Service which will replace CHIEF.

Funding will be provided to pharmacies to identify cancer in patients, the NHS Chief Executive Amanda Pritchard has announced.